Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Sold by Triasima Portfolio Management inc.

Triasima Portfolio Management inc. trimmed its position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 75.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 95,960 shares of the company's stock after selling 301,137 shares during the quarter. Triasima Portfolio Management inc. owned about 0.25% of Viemed Healthcare worth $753,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Ameritas Investment Partners Inc. bought a new stake in shares of Viemed Healthcare during the second quarter valued at approximately $28,000. Lazard Asset Management LLC bought a new position in Viemed Healthcare during the fourth quarter valued at approximately $32,000. UBS Group AG boosted its stake in Viemed Healthcare by 75.4% during the first quarter. UBS Group AG now owns 4,291 shares of the company's stock valued at $41,000 after buying an additional 1,844 shares during the last quarter. Cubist Systematic Strategies LLC bought a new position in Viemed Healthcare during the first quarter valued at approximately $44,000. Finally, State Board of Administration of Florida Retirement System bought a new position in Viemed Healthcare during the third quarter valued at approximately $67,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Price Performance

Viemed Healthcare stock traded down $0.07 during midday trading on Friday, reaching $8.18. 107,962 shares of the stock traded hands, compared to its average volume of 234,302. Viemed Healthcare, Inc. has a 12 month low of $5.90 and a 12 month high of $12.01. The company has a quick ratio of 1.05, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock's fifty day moving average is $8.91 and its 200-day moving average is $7.95. The stock has a market cap of $317.06 million, a P/E ratio of 31.46 and a beta of 1.51.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its quarterly earnings data on Wednesday, March 6th. The company reported $0.09 earnings per share (EPS) for the quarter. Viemed Healthcare had a return on equity of 9.59% and a net margin of 5.60%. The business had revenue of $50.74 million for the quarter.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.